55
Participants
Start Date
February 5, 2008
Primary Completion Date
August 3, 2010
Study Completion Date
July 17, 2014
PF-00299804
Single arm (no comparator) study, oral once daily dosing, dose escalation (it is a phase 1/2 study) until disease progression, unacceptable toxicity or withdrawal of consent
Seoul National University Hospital, Department of Internal Medicine, Seoul
Severance Hospital, Yonsei University College of Medicine, Yonsei Cancer Center, Seoul
Samsung Medical Center, Department of Medicine, Seoul
Lead Sponsor
Pfizer
INDUSTRY